Average Co-Inventor Count = 7.84
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (16 from 2,405 patents)
2. Merck + Co., Inc. (6 from 4,770 patents)
3. Msd R&d (china) Co., Ltd. (1 from 10 patents)
4. Merck Shapr & Dohme Corp. (1 from 1 patent)
5. Msd R&d Co., Ltd. (0 patent)
23 patents:
1. 10285989 - Pyrimidinone amide compounds as PDE2 inhibitors
2. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
3. 9815796 - Pyrimidone carboxamide compounds as PDE2 inhibitors
4. 9717714 - Spirocyclic CETP inhibitors
5. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
6. 9540364 - Benzimidazole tetrahydrofuran derivatives
7. 9527839 - Benzimidazole tetrahydropyran derivatives
8. 9382243 - Azabenzimidazole tetrahydropyran derivatives
9. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
10. 9221834 - Cyclic amine substituted oxazolidinone CETP inhibitor
11. 8980929 - Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
12. 8853212 - Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
13. 8796258 - Cyclic azabenzimidazole derivatives useful as anti-diabetic agents
14. 8653059 - Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
15. 8455533 - Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes